Average Insider

Where insiders trade, we follow

$DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Healthcare
Sector
Medical - Care Facilities
Industry
Javier J. Rodriguez
CEO
76000
Employees
$149.31
Current Price
$9.96B
Market Cap
52W Low$101.00
Current$149.3182.7% above low, 17.3% below high
52W High$159.42

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00--All Sells
Sells11$199,939,880.731,658,480
3 monthsBuys00--All Sells
Sells11$199,939,880.731,658,480
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jan 29, 2026
BERKSHIRE HATHAWAY INC
10% Owner
Sale1,658,480$120.56$199,939,880.73View Details
12 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
May 11, 2026
EPS
Estimated$2.41
ActualN/A
Revenue
EstimatedN/A
ActualN/A

Past Earnings

Historical earnings results
Feb 12, 2026
EPS
Estimated$3.24
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Feb 2, 2026
EPS
Estimated$3.24
Actual$3.40
Beat
Revenue
Estimated$3.34B
Actual$3.62B
Beat
3 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.3.23